North America to maintain its dominance throughout the forecast period

By -

 Surge in geriatric population, increase in incidences of diabetes, obesity and chronic conditions, and high-end technological advancements to deal with complex wounds fuel the growth of the global advanced wound care market. On the other hand, high cost of advanced wound care products impedes the growth to some extent. Nevertheless, untapped opportunities in developing economies is expected to create a number of opportunities for the key players in the industry.

The global advanced wound care industry was estimated at $8.45 billion in 2018 and is expected to reach $13.94 billion by 2027, growing at a CAGR of 6.5% from 2019 to 2027.

The therapy devices segment to maintain its leadership status till 2027-

Based on product, the therapy devices segment accounted for more than one-third of the global advanced wound care market share in 2018, and is expected to rule the roost throughout the forecast period. Availability of innovative portfolio for wound care devices, rise in government spending, surge in awareness toward healthcare, and technological advancements are the major factors fueling the growth of the segment. At the same time, the active wound care segment would grow at the fastest CAGR of 17.4% during the study period. Increase in number of plastic surgeries, surge in demand for innovative & advanced wound care products, and rise in incidence of burns & trauma injuries across the globe have boosted the growth of the segment.

The chronic wounds segment to remain lucrative during the estimated period-

Based on application, the chronic wounds segment contributed to more than two-thirds of the global advanced wound care market in 2018, and is anticipated to dominate during 2019–2026. The same segment is also projected to register the fastest CAGR of 6.7% by 2026. Various methods are now available to treat chronic wounds, including, debridement, moist wound healing, vacuum-assisted closure, oxygenation, warming etc., which has driven the growth of the segment.

North America to maintain its dominance throughout the forecast period-

Based on geography, North America held the major share in 2018, generating nearly two-fifths of the global advanced wound care market. Development of advanced systems, upsurge in adoption of wound care products for the treatment of chronic & acute wounds, increase in incidence of chronic diseases, and surge in geriatric population have boosted the market in the province. The region across Asia-Pacific, on the other hand, would cite the fastest CAGR of 8.4% throughout the estimated period. Development in healthcare infrastructure, rise in number of laboratories with advanced medical facilities, and increase in number of target population in emerging economies have propelled the growth.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/903 

Key market players–

  • Adynxx, Inc.
  • 3M (Acelity Inc.)
  • Smith & Nephew Plc.
  • Coloplast A/S
  • ConvaTec Group Plc.
  • AB (Mölnlycke Health Care AB)
  • Essity AB (BSN Medical GmbH)
  • Medtronic Plc.
  • Integra Lifesciences (Derma sciences)
  • Investor Johnson & Johnson
  • Medline Industries, Inc.
  • B Braun Melsungen AG
  • Organogenesis Holdings Inc.

Comments

Post a Comment

Popular posts from this blog

Global Cancer pain market is segmented based on drug type, disease indication, and region.

By -
According to a new report published by Allied Market Research, titled, "Cancer Pain Market by Type and Application: Global Opportunity Analysis and Industry Forecast, 2018 - 2025,"  the global cancer pain market was valued at $5,285 million in 2017, and is expected to reach $7,545 million by 2025, growing at a CAGR of 4.5% from 2018 to 2025. Download the Sample Report @  https://www.alliedmarketresearch.com/request-sample/5123?utm_source=Blogger&utm_medium=Niranjan Cancer pain is chronic in nature and is commonly associated with cancer. It results from tissue damage, either due to the disease itself or due to different treatments such as chemotherapy, radiotherapy, or surgery. Cancer pain drugs are expected to exhibit significant market growth during the forecast period due to growth in demand for the drugs, surge in prevalence of cancer across the globe, increase in number of R&D activities to develop ideal cancer pain medications, and rise in the unmet nee...
Read more

U.S. was the largest country market in 2015, and is projected to maintain its lead until 2022.

By -
Image
  Surge in usage of wireless monitoring devices and increase in population of aging people across the globe drive the growth of the global patient monitoring devices market. However, high cost associated with patient monitoring devices is anticipated to restrain the market growth. Furthermore, increasing technological advancements are expected to provide new opportunities during the forecast period. The  Patient Monitoring Devices Market  generated $25.76 billion in 2019, and is estimated to reach $44.86 billion by 2027, registering a CAGR of 4.4% from 2020 to 2027. Based on product type, the cardiac monitoring devices segment contributed to the largest share in 2019, accounting for more than one-fourth of the total share, and is estimated to maintain its dominant position during the forecast period. However, the remote patient monitoring devices segment is estimated to portray the highest CAGR of 6.3% during the forecast period. Based on end-user, the hospitals segment a...
Read more